Evonik has started the construction of a production facility for organically modified specialty silicones in Shanghai (China). The project is part of a global investment initiative. A first expanded production plant became operational in Essen in late 2014. The new facility is being constructed at the Multi-User-Site (MUSC) in the Shanghai Chemical Industry Park, with completion planned for mid of 2017. The investment volume is in the high double-digit million euro range.

´"With this investment, we are strengthening our position as market and technology leader" said Klaus Engel, the chairman of the Evonik Executive Board, during the groundbreaking ceremony in Shanghai. "We want to expand our specialty silicones production capacities in Asia to serve the rising demand with local production.“ That is why we are enlarging our production capacities in this region."

"Based on our successful business operations in Shanghai for more than 15 years, we want to continue to support the success and growth of our customers in Asia and beyond as a reliable partner," said Dr. Hans Josef Ritzert, member of the Board of Management of Evonik Nutrition & Care GmbH.